Home/Filings/4/0001246360-12-001017
4//SEC Filing

Smoller David Adam 4

Accession 0001246360-12-001017

CIK 0000090185other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 9:55 PM ET

Size

17.5 KB

Accession

0001246360-12-001017

Insider Transaction Report

Form 4
Period: 2012-02-13
Smoller David Adam
President, Research Biotech
Transactions
  • Award

    ISO Stock Option Right To Buy

    2012-02-14$70.32/sh+1,422$99,9951,422 total
    Exercise: $70.32From: 2013-02-14Exp: 2022-02-14Common Stock (1,422 underlying)
  • Award

    NQ Stock Option, Right To Buy

    2012-02-14$70.32/sh+16,078$1,130,60516,078 total
    Exercise: $70.32From: 2013-02-14Exp: 2022-02-14Common Stock (16,078 underlying)
  • Award

    Common Stock

    2012-02-13+2,81610,945 total
  • Exercise/Conversion

    NQ Stock Option, Right to Buy

    2012-02-148,00013,943 total
    Exercise: $48.61From: 2011-02-16Exp: 2020-02-16Common Stock (8,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-02-14$52.76/sh+4,283$225,97115,228 total
  • Exercise/Conversion

    Common Stock

    2012-02-14$48.61/sh+8,000$388,88023,228 total
  • Exercise/Conversion

    NQ Stock Option Right To Buy

    2012-02-144,2830 total
    Exercise: $52.76From: 2009-02-15Exp: 2018-02-15Common Stock (4,283 underlying)
  • Sale

    Common Stock

    2012-02-14$70.15/sh12,283$861,68310,945 total
Footnotes (2)
  • [F1]The options vest in three equal installments beginning on February 14, 2013.
  • [F2]The options vested in three equal installments on February 15, 2009, 2010, 2011.

Issuer

SIGMA ALDRICH CORP

CIK 0000090185

Entity typeother

Related Parties

1
  • filerCIK 0001335952

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 9:55 PM ET
Size
17.5 KB